SEI Investments’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Other funds holding TSHA
ACA
RCM
VPC
RI
SEI Investments's TSHA Position: Q2 2026 in Review
SEI Investments reduced its Taysha Gene Therapies (TSHA) stake by 73% in Q2 2026, selling an estimated $222K and leaving 13,952 shares worth $95K. The position accounts for ﹤0.01% of the portfolio, ranked #3192.
SEI Investments first reported a position in TSHA in Q3 2024 and has held it in 4 quarters since. The position peaked at $263K in Q4 2025. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.
- SEI Investments held 13,952 shares of Taysha Gene Therapies worth $95K as of Q2 2026.
- SEI Investments sold 37,520 Taysha Gene Therapies shares in Q2 2026, an estimated $222K.
- Taysha Gene Therapies made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3192 holding.
- SEI Investments first reported a position in Taysha Gene Therapies in Q3 2024 and has held it in 4 quarters since.
- SEI Investments's Taysha Gene Therapies position peaked at $263K in Q4 2025.
- 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.